Fermer le menu

Member of Lyonbiopole


NETRIS Pharma is a clinical stage immune-oncology company developing therapeutic molecules for targeted therapy of cancer, based on the innovative concept of dependence receptors. The lead asset is a anti-netrin-1 blocking antibody that is currently assessed in various phase 2 clinical trials.


Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide

Created on june 26th, 2008 - 13 employees



Centre Léon Bérard
28 rue Laennec 69008 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.